CHEMICAL/BIOLOGICAL DEFENSE (APPLIED RESEARCH)
Abstract
The projects in this program element (PE) support applied research in the areas of physical technologies, non-traditional agent (NTA) medical and physical defense technologies, and medical technologies. Major efforts support development of vaccines, therapeutics, next generation diagnostics systems, next generation chemical detectors, nerve agent pretreatments, and individual protection advances. Individual projects include: - Chemical Biological Defense (CB2): continual improvements in CB physical sciences defense materiel, including contamination avoidance, decontamination, detection and protection technologies, as well as biological weapon/agent surveillance (e.g. CB protective materials, textiles, and filtration, sensors and sensing algorithms, effects modeling, chemical formulations, processes, and methods for hazard mitigation). - NTA Defense (NT2): consolidation of all NTA efforts (both medical and non-medical) including pretreatments, therapeutics, detection, threat agent science, modeling, protection and hazard mitigation and characterization of emerging threats - Medical Defense (TM2): development of antidotes, drug treatments, disease surveillance and point-of-need diagnostic devices, patient decontamination and medical technologies management (e.g. drug discovery and platform technology development, biomarkers and assay development useful in drug development and diagnostics, human mimicking devices and regulatory science). CBDP S&T Applied Research Stakeholders: United States Army Edgewood Chemical Biological Center (ECBC), United States Army Medical Research Institute of Infectious Diseases (USAMRIID), United States Army Medical Research Institute of Chemical Defense (USAMRICD), United States Army Natick Soldier Systems Center, Naval Research Lab (NRL), Air Force Research Lab (AFRL), among others. The intent is to maintain strategic partnerships with the DoD Service communities for mission success across the enterprise through collaborative planning and programming maintaining budget assurance. Efforts under this PE will transition to or will provide risk reduction for Advanced Technology Development (PE 0603384BP), Advanced Component Development and Prototypes (PE 0603884BP), and System Development and Demonstration (PE 0604384BP).
Document Details
- Document Type
- R2 Budgetary Justification
- Publication Date
- Oct 01, 2020
- Source ID
- 0602384BP_2_0400_PB_2020
- Change Summary Explanation
- Funding: FY18 (+$2.000M): Congressional add for program increase to Chemical Biological Defense (CB2). FY18 (+$0.715M): Reprogramming to support therapeutics projects. FY18 (-$4.302M): Transfer of funding to support Small Business Innovative Research/Small Business Technology Transfer efforts. FY20 (+$8.526M): Threat Agent Science funding increased to expand threat characterization and assessments to minimize surprise from emerging and advanced CBRN threats. Schedule: N/A Technical: N/A
- Service Agency Name
- Chemical and Biological Defense Program
Related Documents
- Child Project: CHEMICAL BIOLOGICAL DEFENSE (APPLIED RESEARCH)
- Child Accomplishment: 1) Material Contamination Mitigation
- Child Accomplishment: 2) Respiratory and Ocular Protection
- Child Accomplishment: 3) Percutaneous Protection
- Child Accomplishment: 4) Expeditionary Collective Protection
- Child Accomplishment: 5) Personnel Contamination Mitigation
- Child Accomplishment: 6) Biosurveillance
- Child Accomplishment: 7) Detection Sensor Technologies
- Child Accomplishment: 8) Warning and Reporting
- Child Accomplishment: 9) Hazard Prediction
- Child Accomplishment: 10) Data Analysis
- Child Accomplishment: 11) Data Analysis
- Child Accomplishment: 12) Decision Analysis and Management
- Child Accomplishment: 13) Threat Agent Sciences
- Child Accomplishment: 14) Operational Effects and Planning
- Child Accomplishment: 15) Threat Surveillance
- Child Project: TECHBASE NON-TRADITIONAL AGENTS DEFENSE (APPLIED RESEARCH)
- Child Accomplishment: 1) Expeditionary Collective Protection
- Child Accomplishment: 2) Material Contamination Mitigation
- Child Accomplishment: 3) Personnel Contamination Mitigation
- Child Accomplishment: 4) Respiratory and Ocular Protection
- Child Accomplishment: 5) Chemical Therapeutics - Medical
- Child Accomplishment: 6) Modeling & Simulation
- Child Accomplishment: 7) Percutaneous Protection
- Child Accomplishment: 8) Threat Agent Sciences
- Child Accomplishment: 9) Chemical Pretreatments and Prophylactics - Medical
- Child Project: TECHBASE MED DEFENSE (APPLIED RESEARCH)
- Child Accomplishment: 1) Biosurveillance
- Child Accomplishment: 2) Chemical Diagnostics
- Child Accomplishment: 3) Diagnostic Assays
- Child Accomplishment: 4) Next Generation Diagnostics
- Child Accomplishment: 5) Medical Diagnostics
- Child Accomplishment: 6) Viral/Bacterial/Toxins Vaccines
- Child Accomplishment: 7) Vaccine Platforms and Research Tools
- Child Accomplishment: 8) Viral Therapeutics
- Child Accomplishment: 9) Bacterial Therapeutics
- Child Accomplishment: 10) Toxin Therapeutics
- Child Accomplishment: 11) Chemical Therapeutics
- Child Accomplishment: 12) Pretreatments and Prophylactics, Nerve Agents